Skip to content

Clinical trials

Reperfusion Injury trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20111
20131
20153
20167
20172
20202
20211
20222
20233
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15
Completed8
Recruiting6
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital5
First Affiliated Hospital, Sun Yat-Sen University2
RenJi Hospital2
The Second Hospital of Anhui Medical University2
Affiliated Hospital of Nantong University1
Beijing Anzhen Hospital1
Beijing Tsinghua Chang Gung Hospital1
Capital Medical University1
Central South University1
Chen Wei Ren, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury31
Ischemic Stroke4
Cardiovascular Diseases2
Kidney Tubular Necrosis, Acute2
Myocardial Infarction2
Acute Kidney Injury1
Brain Edema1
Breast Neoplasms1
Cholestasis1
Delayed Graft Function1

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.